BACKGROUND: Adults with cancer may be considered for extracorporeal life support (ECLS) as a means of support if failing conventional therapy. METHODS: The Extracorporeal Life Support Organization Registry was queried for patients aged >or=21 years with diagnoses of malignancy or hematopoietic stem cell transplantation. RESULTS: Seventy-two adults met inclusion criteria: 47 with solid tumors, 21 with hematologic malignancies, and 4 with hematopoietic stem cell transplantation. Patients required ECLS primarily for pulmonary support (n = 54). The median duration of ECLS was 4.1 days. Overall, 44 patients (61%) died on ECLS, 23 (32%) survived to hospital discharge, and 5 (7%) survived ECLS but died before discharge. Risk factors for death include pulmonary support as reason for ECLS, impaired lung function before ECLS, and development of infection. CONCLUSIONS: Adults with cancer can be offered ECLS with a small but real expectation for survival. Impaired pulmonary status and the development of infections are associated with death. Copyright 2010 Elsevier Inc. All rights reserved.
BACKGROUND: Adults with cancer may be considered for extracorporeal life support (ECLS) as a means of support if failing conventional therapy. METHODS: The Extracorporeal Life Support Organization Registry was queried for patients aged >or=21 years with diagnoses of malignancy or hematopoietic stem cell transplantation. RESULTS: Seventy-two adults met inclusion criteria: 47 with solid tumors, 21 with hematologic malignancies, and 4 with hematopoietic stem cell transplantation. Patients required ECLS primarily for pulmonary support (n = 54). The median duration of ECLS was 4.1 days. Overall, 44 patients (61%) died on ECLS, 23 (32%) survived to hospital discharge, and 5 (7%) survived ECLS but died before discharge. Risk factors for death include pulmonary support as reason for ECLS, impaired lung function before ECLS, and development of infection. CONCLUSIONS: Adults with cancer can be offered ECLS with a small but real expectation for survival. Impaired pulmonary status and the development of infections are associated with death. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Heidi J Dalton; Pamela Garcia-Filion; Richard Holubkov; Frank W Moler; Thomas Shanley; Sabrina Heidemann; Kathleen Meert; Robert A Berg; John Berger; Joseph Carcillo; Christopher Newth; Richard Harrison; Allan Doctor; Peter Rycus; J Michael Dean; Tammara Jenkins; Carol Nicholson Journal: Pediatr Crit Care Med Date: 2015-02 Impact factor: 3.624
Authors: Adalgiza M Moreno; Renata R T Castro; Pedro P S Sorares; Mauricio Sant' Anna; Sergio L d Cravo; Antônio C L Nóbrega Journal: J Cardiothorac Surg Date: 2011-04-27 Impact factor: 1.637
Authors: Hye Seon Kang; Chin Kook Rhee; Hea Yon Lee; Young Kyoon Kim; Soon Seog Kwon; Seok Chan Kim; Jong Wook Lee Journal: Korean J Intern Med Date: 2015-06-29 Impact factor: 2.884